ABT Abbott Laboratories
Healthcare$87.41-0.41%ClosedMarket Cap: $152.25B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$127.46
Target (Median)
$125.00
Target Range
$92.00 - $152.00
Upside from current price: 45.8%
Rating Distribution
5 Strong Buy16 Buy7 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-27 | BTIG | maintain | Buy | Buy |
| 2026-04-20 | Barclays | maintain | Overweight | Overweight |
| 2026-04-17 | B of A Securities | maintain | Buy | Buy |
| 2026-04-17 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-04-17 | RBC Capital | maintain | Outperform | Outperform |
| 2026-04-17 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-04-17 | Oppenheimer | maintain | Outperform | Outperform |
| 2026-04-17 | Stifel | maintain | Buy | Buy |
| 2026-04-17 | Benchmark | maintain | Buy | Buy |
| 2026-04-09 | Goldman Sachs | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $6.06 | $54.96B | 16 |
| Sun Dec 31 | $6.76 | $58.95B | 9 |
| Mon Dec 31 | $7.56 | $63.43B | 3 |
| Tue Dec 31 | $8.36 | $68.25B | 3 |